DCPH - Deciphera Pharmaceuticals Inc. (DCPH) CEO Steve Hoerter on Q2 2021 Results - Earnings Call Transcript
Deciphera Pharmaceuticals, Inc. (DCPH) Q2 2021 Earnings Conference Call August 3, 2021 16:30 ET Company Participants Jen Robinson - Vice President, Investor Relations Steve Hoerter - President and Chief Executive Officer Dan Martin - Chief Commercial Officer Matt Sherman - Chief Medical Officer Tucker Kelly - Chief Financial Officer Conference Call Participants Daniel Wolle - JPMorgan Chris Raymond - Piper Sandler Eun Yang - Jefferies Charles Zhu - Guggenheim Securities Srikripa Devarakonda - Truist Securities Reni Benjamin - JMP Securities Peter Lawson - Barclays Arlinda Lee - Canaccord Presentation Operator Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Jen Robinson, Vice President of Investor Relations, Jen? Jen Robinson Thank you operator. Welcome, and thank you for joining us today to discuss Deciphera second quarter 2021
For further details see:
Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q2 2021 Results - Earnings Call Transcript